TABLE 3.
Description of 12 patients with positive peritoneal cytology.
| Study ID | Age | Method of diagnosis | Diagnosis | FIGO stage | Myometrial invasion | LVSI | Distant metastasis |
| 54 | 61 | D&C | Endometrioid carcinoma 70% mixed serous carcinoma 30% | IIIc1 | >1/2 | Y | Pelvic lymph node |
| 63 | 61 | D&C | Endometrioid carcinoma FIGO G2 | IIIA | >1/2 | N | Bilateral accessary |
| 139 | 61 | Hysteroscopy | Non-keratinized squamous cell carcinoma | IIIC2 | >1/2 | Y | Para-aortic lymph node |
| 158 | 46 | D&C | Endometrioid carcinoma FIGO G1 | IA | <1/2 | N | None |
| 174 | 50 | D&C | Endometrioid carcinoma FIGO G1 | II | <1/2 | N | Cervix |
| 211 | 43 | D&C | Endometrioid carcinoma FIGO G3 mixed clear cell carcinoma | IIIC1 | >1/2 | Y | Pelvic lymph node |
| 240 | 41 | D&C | Endometrioid carcinoma FIGO G1 | IA | >1/2 | N | None |
| 243 | 61 | D&C | Serous carcinoma | IVB | >1/2 | Y | Peritoneal, Omental, and accessary (L) |
| 289 | 52 | Hysteroscopy | Mixed clear cell carcinoma 65%, Serous carcinoma 30% and Endometrioid carcinoma 5% | IVA | >1/2 | N | Sigmoid colon |
| 304 | 52 | D&C | Endometrioid carcinoma FIGO G1 | IA | >1/2 | N | None |
| 360 | 60 | D&C | Endometrioid carcinoma FIGO G3 | IVB | >1/2 | N | Cervix, Parametrium, Omental, and bilateral accessary |
| 429 | 54 | Hysteroscopy | Endometrioid carcinoma FIGO G2 | IA | >1/2 | Y | None |